Inhibikase Therapeutics Files 8-K on Financials
Ticker: IKT · Form: 8-K · Filed: May 14, 2025 · CIK: 1750149
| Field | Detail |
|---|---|
| Company | Inhibikase Therapeutics, INC. (IKT) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, financial-statements, 8-k
Related Tickers: IKT
TL;DR
IKT filed an 8-K on 5/14/25 detailing financial results and exhibits.
AI Summary
Inhibikase Therapeutics, Inc. filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial status. The company is incorporated in Delaware and its principal executive offices are located in Wilmington, DE.
Why It Matters
This filing provides investors with crucial updates on Inhibikase Therapeutics' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any new material events or significant negative news.
Key Players & Entities
- Inhibikase Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Wilmington, DE (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Inhibikase Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Inhibikase Therapeutics, Inc., and to include Financial Statements and Exhibits.
On what date was this 8-K filing reported as of?
The date of the earliest event reported is May 14, 2025.
In which state is Inhibikase Therapeutics, Inc. incorporated?
Inhibikase Therapeutics, Inc. is incorporated in Delaware.
What is the address of Inhibikase Therapeutics, Inc.'s principal executive offices?
The address of Inhibikase Therapeutics, Inc.'s principal executive offices is 1000 N. West Street, Suite 1200, Wilmington, DE 19801.
What is the IRS Employer Identification Number for Inhibikase Therapeutics, Inc.?
The IRS Employer Identification Number for Inhibikase Therapeutics, Inc. is 26-3407249.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Inhibikase Therapeutics, Inc. (IKT).